{'text': 'Novartis AG Doubles Down on Immuno-Oncology, Acquires Admune and Inks Deals With XOMA and Palobiofarma', 'publisher': {'href': 'https://www.biospace.com', 'title': 'BioSpace'}, 'created_at': 'Wed, 21 Oct 2015 07:00:00 GMT', 'description': 'Novartis AG Doubles Down on Immuno-Oncology, Acquires Admune and Inks Deals With XOMA and Palobiofarma  BioSpace', 'url': 'https://news.google.com/rss/articles/CBMizwFBVV95cUxOblZ0eHNZVGtkVkR0c3RMQkp4bFY5YWh1VHllVE5Oa3hrZEhMYU8xZHJ4MWhFbm5rVUptYWE3a0hFaV9odnF1RnY4WVNjaU5wX3lqMUozaWxJTXJhZ0dfN3NqNGp0VGhNVVJ2OC1wS2ZkaWhaTmZ3d0tTa1VKNndWWlhiOGhJUlJTdTdlR3pvRURZOG1CRm5LUWVaOWNkUno2MHNHZVlaeGl3YlNFNUd3Z29RYU5iT3U5dkxGVGtwUEo0Zjg5eTJidVIzRXBGcEE?oc=5&hl=en-US&gl=US&ceid=US:en'}
